sars-cov-2 vaccine
Generic: SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein·Brand: Comirnaty, Nuvaxovid 2025-2026, Spikevax
sars-cov-2 vaccine: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| GENETHERA INC (GTHR) | Preclinical |
Get deeper analysis on sars-cov-2 vaccine
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis